Intelligent Bio Solutions Inc. told the SEC it sent a request to the FDA for approval of its drug test.

Sep 9, 2026, 8:54 AM ETTrialRead the original at sec.gov

Good for INBS

Intelligent Bio Solutions submitted a 510(k) to the FDA for a codeine test. This advances its path toward commercial sales if the device is cleared.

INBS · Intelligent Bio Solutions Inc.

AI read · Good for INBS

The AI's read

Intelligent Bio Solutions announced an FDA 510(k) submission for its Intelligent Fingerprinting drug screening system. That seeks clearance to detect the opiate codeine and could let the company sell the test if cleared.

Get alerts for INBS

Follow Intelligent Bio Solutions Inc. (INBS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for INBS

Free on the App Store and Google Play, or on the web.